6.1 Clinical response |
4 |
447 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.83 [1.40, 2.38] |
6.1.1 Amitriptyline + perphenazine vs perphenazine |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.61 [1.23, 10.56] |
6.1.2 Fluoxetine + olanzapine vs olanzapine |
2 |
149 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.64 [1.10, 2.44] |
6.1.3 Olanzapine + sertraline vs olanzapine |
1 |
259 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.76 [1.21, 2.54] |
6.2 Dropouts |
4 |
447 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.79 [0.63, 1.01] |
6.2.1 Amitriptyline + perphenazine vs perphenazine |
1 |
39 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.09 [0.38, 25.19] |
6.2.2 Fluoxetine + olanzapine vs olanzapine |
2 |
149 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.95 [0.59, 1.53] |
6.2.3 Olanzapine + sertraline vs olanzapine |
1 |
259 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.70 [0.53, 0.92] |